COMPANY

Longevity Biotech

HQ: Philadelphia, PA source · longevitybiotech.com ↗ · Mid-Atlantic

Keywords: neurology Parkinson's disease Parkinson Disease

Location: Philadelphia, PA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Jul 10, 2018 Trial start —: Parkinson's Disease Inflammatory Biomarker Profiling source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT03633513	Parkinson's Disease Inflammatory Biomarker Profiling	Not listed	Terminated	Jul 10, 2018	Mar 13, 2020 (actual)

Annual award amounts. Total $225K.

2017 NIH contract (government contract; not a grant and not an investment round) 268201700022C-0-0-1 FY2017: $225,000 awarded for that fiscal year; activity N43 (OTHER_NIH); PI SHANDLER, SCOTT; recipient as written: LONGEVITY BIOTECH, INC., PHILADELPHIA, PA. IGF::O source ↗